Marco Meglio, Assistant Managing Editor for NeurologyLive, has been with the team since October 2019. Follow him on Twitter @marcomeglio1 or email him at mmeglio@neurologylive.com
MDA Study Highlights Lack of Psychosocial Care Services for Duchenne Muscular Dystrophy
March 23rd 2025Despite facing mental health concerns with anger, aggression, or irritability, among others, slightly less than one-fourth of patients with DMD utilized psychosocial services such as counseling or therapy.
Breaking Barriers: Donovan Decker’s Journey in Gene Therapy and Advocacy for LGMD
March 20th 2025Donovan Decker, recipient of the 2025 MDA Legacy Award for Community Impact and Research, shared his powerful journey as a patient advocate and gene therapy pioneer, shedding light on the challenges and progress in LGMD.
World Sleep Day with Dr. Eric Olson: Advancing Sleep Health and Awareness
March 14th 2025On World Sleep Day, the president of the American Academy of Sleep Medicine discussed the importance of sleep for health, the risks of sleep deprivation, nonpharmacologic strategies to improve sleep, and the need for greater awareness of sleep disorders.
Rethinking Rest on World Sleep Day: Neurologist’s Take on Sleep Priorities
March 14th 2025Anne Marie Morse, DO, director of Child Neurology and Pediatric Sleep Medicine at Geisinger Janet Weis Children’s Hospital, dove into the importance of sleep health, its impact on brain function, and emerging research in honor of World Sleep Day.
Misdiagnosed Migraine Leads to Significant Burden on Healthcare Resource Utilization
March 13th 2025New research highlights the significant economic burden of misdiagnosed migraine patients, revealing higher healthcare costs and resource utilization over time compared to those with accurate diagnoses.
Kinetic Oscillation Stimulation Proves to be Therapeutically Beneficial for Chronic Migraine
March 11th 2025Treatment with the Chordate System led to a significantly greater reduction in monthly headache days during the performance assessment period, with a reduction of 3.5 days compared to 1.2 days in the sham group.
Repair, Remyelination, and Progress: What’s Driving MS Innovation in 2025?
March 11th 2025Daniel Ontaneda, MD, PhD, an associate professor of neurology at the Cleveland Clinic Lerner College of Medicine, gave thoughts and perspectives on some of the emerging, promising advances in multiple sclerosis care expected to come to fruition in 2025.